UK pharmaceuticals companies are introducing new drug pricing models as pressure mounts to offer better value for money.

The National Institute for Health and Clinical Excellence (Nice), the government's medicines advisory body that studies clinical and cost effectiveness, has agreed three different experimental approaches to pricing with drug companies in the past year alone.